When was pharma-bio-key founded?

pharma-bio-key was founded in 2020.

Where is pharma-bio-key located?

pharma-bio-key is headquartered in Flushing, United States.

Is pharma-bio-key a funded company?

pharma-bio-key is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does pharma-bio-key rank among its competitors?

pharma-bio-key ranks 436th amongst 482 active competitors, of which 11 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abacus Medicine, which secured $206K in Jul, 2020.

Who are the top competitors of pharma-bio-key?

pharma-bio-key's top competitors include OPEN Health, Abacus Medicine and Secura Bio. Among them, Abacus Medicine secured the most recent funding round in July, 2020.

pharma-bio-key - 2026 Company Profile & Competitors

Most viewed in 2019

pharma-bio-key is an unfunded company based in Flushing (United States), founded in 2020. It operates as a Provider of consulting and marketing services to the pharmaceutical industry. pharma-bio-key has not raised any funding yet. The company has 482 active competitors, including 11 funded and 49 that have exited. Its top competitors include companies like OPEN Health, Abacus Medicine and Secura Bio.

Key Metrics

Founded Year

2020

Location

Flushing, United States

Stage

Unfunded

Ranked

436^th among 482 active competitors

Similar Companies

OPEN Health & 541 more

View pharma-bio-key's full profile

pharma-bio-key has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of pharma-bio-key include OPEN Health, Abacus Medicine and Secura Bio. Here is the list of Top 10 competitors of pharma-bio-key, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OPEN Health 2016, Marlow (United Kingdom), Acquired	Provider of healthcare marketing services	$5.28M	LBO France, Amulet Capital Partners	62/100
2nd	Abacus Medicine 2004, Copenhagen (Denmark), Series A	Consulting services for market access, health economics and outcomes research	$57.6M	Chr. Augustinus Factories	56/100
3rd	Secura Bio 2018, Henderson (United States), Series A	Provider of consulting services for market access and health outcomes	$55M	Athyrium Capital Management	48/100
4th	PHMR 2007, London (United Kingdom), Acquired	Provider of market access services	-	-	44/100
5th	GBA Group 1975, Hamburg (Germany), Acquired	Provider of drinking water testing, environmental analysis, and marketing services to the pharmaceutical industry	-	Adiuva Capital	44/100
6th	Target RWE 2017, Durham (United States), Acquired	Provider of marketing services to the pharmaceutical industry	-	Norwest, VentureSouth	43/100
7th	BioPharm Communications 2005, New Hope (United States), Acquired	Provider of marketing services to pharmaceutical and biopharma companies	-	Boathouse Capital, Abacus Finance Group & 2 others	43/100
8th	Bridge Medical 2011, Chatham (United Kingdom), Acquired	Provider of evidence and outcomes research for biopharmaceutical companies	-	-	41/100
9th	Taevas Global 2019, Hyderabad (India), Unfunded	Provider of market entry and regulatory compliance services for life sciences companies	-	-	41/100
10th	bpcruk 2016, United Kingdom, Public	Provider of marketing services to biopharma sector	-	Scientia Ventures	40/100
436th	pharma-bio-key 2020, Flushing (United States), Unfunded	Provider of consulting and marketing services to the pharmaceutical industry	-	-	16/100